Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3

Blood (2015) 125 (25): 3886–3895.

https://doi.org/10.1182/blood-2014-12-618363

Published: 2015

Includes: Supplemental data

Journal Articles

Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed against Mismatched HLA Class I

Avital L. Amir, MD, Renate S. Hagedoorn, MSC, W.A. Eric Marijt, MD, PhD, Roel Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2008) 112 (11): 4607.

https://doi.org/10.1182/blood.V112.11.4607.4607

Published: 2008

Journal Articles

Generating of Human CD4 + and CD8 + T Lymphocytes toward NY-ESO-1 by T Cell Receptor (TCR) Modification and Transduction for Adoptive TCR Gene-Transfer

Holger Krönig, MD, Kathrin Hofer, Daniel Sommermeyer, Christian Peschel, MD, Wolfgang Uckert, Helga Bernhard, MD

Blood (2008) 112 (11): 3533.

https://doi.org/10.1182/blood.V112.11.3533.3533

Published: 2008

Journal Articles

Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed Against Mismatched HLA Class I.

Avital Amir, MD, Renate S. Hagendoorn, Erik W.A. Marijt, Roelof Willemze, J.H. Frederik Falkenburg, Mirjam Heemskerk

Blood (2007) 110 (11): 5030.

https://doi.org/10.1182/blood.V110.11.5030.5030

Published: 2007

Journal Articles

GVHD in HLA-A2 Mismatched Transplantation Caused by a Combined CD8 Response Directed Against HLA-A2 and a CD4 Response Recognizing an HLA-A2 Derived Peptide in HLA-DR1.

Avital Amir, Menno A.W.G. van der Hoorn, Erik W.A. Marijt, Michel G.D. Kester, Roelof Willemze, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Blood (2006) 108 (11): 5164.

https://doi.org/10.1182/blood.V108.11.5164.5164

Published: 2006

Journal Articles

Determination of a HLA II Promiscuous Peptide Cocktail as Potential Vaccine Against EBV Latency II Malignancies.

Stephane Depil, MD, Olivier Morales, Bernard Maillere, PhD, Nadira Delhem, PhD, Violaine Francois, Bertrand Georges, PhD, Franck Morschhauser, MD, Claude Auriault, PhD, Veronique Pancre, PhD

Blood (2005) 106 (11): 1478.

https://doi.org/10.1182/blood.V106.11.1478.1478

Published: 2005

Journal Articles

Regulation of a Graft-Versus-Leukemia Effect by Major Histocompatibility Complex Class II Molecules on Leukemia Cells: HLA-DR1 Expression Renders K562 Cell Tumors Resistant to Adoptively Transferred Lymphocytes in Severe Combined Immunodeficiency Mice/Nonobese Diabetic Mice

Frank F. Weichold, Yin-zheng Jiang, Daniel E. Dunn, Michael Bloom, Vera Malkovska, Nancy F. Hensel, A. John Barrett

Blood (1997) 90 (11): 4553–4558.

https://doi.org/10.1182/blood.V90.11.4553

Published: 1997

NARROW

Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3

Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed against Mismatched HLA Class I

Generating of Human CD4 + and CD8 + T Lymphocytes toward NY-ESO-1 by T Cell Receptor (TCR) Modification and Transduction for Adoptive TCR Gene-Transfer

Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed Against Mismatched HLA Class I.

GVHD in HLA-A2 Mismatched Transplantation Caused by a Combined CD8 Response Directed Against HLA-A2 and a CD4 Response Recognizing an HLA-A2 Derived Peptide in HLA-DR1.

Determination of a HLA II Promiscuous Peptide Cocktail as Potential Vaccine Against EBV Latency II Malignancies.

Regulation of a Graft-Versus-Leukemia Effect by Major Histocompatibility Complex Class II Molecules on Leukemia Cells: HLA-DR1 Expression Renders K562 Cell Tumors Resistant to Adoptively Transferred Lymphocytes in Severe Combined Immunodeficiency Mice/Nonobese Diabetic Mice

Email alerts

ASH Publications

American Society of Hematology

Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3

Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed against Mismatched HLA Class I

Generating of Human CD4 + and CD8 + T Lymphocytes toward NY-ESO-1 by T Cell Receptor (TCR) Modification and Transduction for Adoptive TCR Gene-Transfer

Leukemic Blasts Acting as Host Antigen Presenting Cells Trigger a Combined CD4 and CD8 Allo-Immune Response Directed Against Mismatched HLA Class I.

GVHD in HLA-A2 Mismatched Transplantation Caused by a Combined CD8 Response Directed Against HLA-A2 and a CD4 Response Recognizing an HLA-A2 Derived Peptide in HLA-DR1.

Determination of a HLA II Promiscuous Peptide Cocktail as Potential Vaccine Against EBV Latency II Malignancies.

Regulation of a Graft-Versus-Leukemia Effect by Major Histocompatibility Complex Class II Molecules on Leukemia Cells: HLA-DR1 Expression Renders K562 Cell Tumors Resistant to Adoptively Transferred Lymphocytes in Severe Combined Immunodeficiency Mice/Nonobese Diabetic Mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only